Free Trial
→ $30 stock to buy before Starlink goes public (WATCH NOW!) (From Paradigm Press) (Ad)tc pixel
NASDAQ:CLIK

Click 5/11/2026 Earnings Report

Click logo
$1.49 -0.19 (-11.31%)
Closing price 05/14/2026 04:00 PM Eastern
Extended Trading
$1.50 +0.01 (+0.67%)
As of 04:30 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
ProfileEarnings HistoryForecast

Click EPS Results

Actual EPS
$0.10
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Click Revenue Results

Actual Revenue
$3.79 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Click Announcement Details

Quarter
Date
5/11/2026
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Click Earnings Headlines

Revenue Growth and Profitability Turnaround Put Click Holdings’ (CLIK) Senior Care Expansion in Focus
May 11, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/sectors/healthcare/articles/revenue-growth-profitability-turnaround-put-150456156.html
Click Holdings Files May 11 Form 6-K Detailing Stronger Interim Balance Sheet
May 11, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/click-holdings-files-may-11-form-6-k-detailing-stronger-interim-balance-sheet?utm_source=marketbeat.com&utm_medium=referral
Ticker Revealed: Pre-IPO Access to "Next Elon Musk" Company
We’ve found The Next Elon Musk… and what we believe to be the next Tesla. It’s already racked up $26 billion in government contracts. Peter Thiel just bet $1 Billion on it.tc pixel
 |  Banyan Hill Publishing (Ad)
CLICK (NASDAQ: CLIK) Reports Strong Revenue Growth and Swings to Profit – Seniors Nursing Sector Skyrocketing over 110%, On Track for HK$500 Million Annual Revenue in 3 Years
May 11, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/05/11/3291688/0/en/click-nasdaq-clik-reports-strong-revenue-growth-and-swings-to-profit-seniors-nursing-sector-skyrocketing-over-110-on-track-for-hk-500-million-annual-revenue-in-3-years.html
The Rise Of 'Zero-Click' Search And What It Means For Your Marketing Budget
April 30, 2026  |  forbes.comhttps://www.forbes.com/councils/forbesbusinesscouncil/2026/04/29/the-rise-of-zero-click-search-and-what-it-means-for-your-marketing-budget/
Click Holdings Buys Into Flash Mutual to Expand in Greater Bay Area Silver Economy
April 28, 2026  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/click-holdings-buys-into-flash-mutual-to-expand-in-greater-bay-area-silver-economy?utm_source=marketbeat.com&utm_medium=referral
See More Click Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Click? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Click and other key companies, straight to your email.

About Click

Click (NASDAQ:CLIK) Therapeutics, Inc. (NASDAQ: CLIK) is a clinical-stage digital therapeutics company developing software-based treatments for neurological, psychiatric and chronic diseases. Its platform delivers prescription digital therapies via mobile and web applications, combining evidence-based cognitive behavioral interventions, digital monitoring tools and patient engagement techniques. Click’s approach is designed to complement or extend traditional pharmacological and behavioral treatments for conditions such as major depressive disorder, insomnia and tobacco use disorder.

Founded in 2014, Click has progressed multiple programs through randomized controlled trials and regulatory review. Several of its lead digital therapeutics have earned Breakthrough Device designation from the U.S. Food and Drug Administration and have pursued CE marking for commercialization in Europe. The company collaborates with pharmaceutical partners, academic institutions and healthcare providers to integrate its digital products into clinical pathways and to collect real-world evidence supporting safety and efficacy.

Headquartered in New York City, Click operates in the United States with strategic alliances in select international markets. Its leadership team draws on deep experience in digital health innovation, neuroscience research and pharmaceutical development. Click continues to invest in research and development, aiming to expand its pipeline into new therapeutic areas and to scale adoption of its digital therapeutics globally.

View Click Profile
Earnings Tools